Alligator Bioscience Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Peter Ostler, was filed 31 May 2022.
Alligator Bioscience: what insiders have been doing
Alligator Bioscience is a listed company. Its directors and officers file their transactions with Finansinspektionen. Alligator Bioscience has had no insider filing for more than a year; the last one goes back to 31 May 2022.
Looking back to 2022, when coverage begins, insiders filed 2 purchases and no sales.
For comparison within the same market, see the insider buying recorded at Dynavox Group AB and Rusta AB (publ). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Financial data
· cache
- 100,000 shares@ SEK 1.51592.1% of flowAktieISIN SE0000767188FI:csv-58439bd459226bcecdd9Canonical exit: 29 Aug 2022 (T+90)
- 100,000 shares@ SEK 0.137.9% of flowOptionISIN SE0018015372FI:csv-d8cb802bed4341fc32caCanonical exit: 28 Aug 2022 (T+90)
2 of 2 declarations
About Alligator Bioscience
Alligator Bioscience is a biopharmaceutical company focused on developing immuno-oncology therapies for cancer treatment. It is listed on the Stockholm Stock Exchange (XSTO).
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations